Detalhe da pesquisa
1.
VARIABLES AFFECTING THE LONG-TERM OUTCOME OF GRAVES ORBITOPATHY FOLLOWING HIGH-DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY.
Endocr Pract
; 22(10): 1177-1186, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27732097
2.
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study.
Thyroid
; 28(3): 386-394, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29336220
3.
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy.
Thyroid
; 25(7): 846-50, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26090805
4.
Role of the underlying thyroid disease on the phenotype of Graves' orbitopathy in a tertiary referral center.
Thyroid
; 25(3): 347-51, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25584927
5.
Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological study.
Eur J Endocrinol
; 172(3): 269-76, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25661744
6.
Spontaneous improvement of untreated mild Graves' ophthalmopathy: Rundle's curve revisited.
Thyroid
; 24(1): 60-6, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23980907
7.
Thyroid volume and severity of Graves' orbitopathy.
Thyroid
; 23(1): 97-102, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23088654
8.
Outcome of Graves' orbitopathy after total thyroid ablation and glucocorticoid treatment: follow-up of a randomized clinical trial.
J Clin Endocrinol Metab
; 97(1): E44-8, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22031515